A federal judge has ruled Zantac class action lawsuits calling for defendants to pay for the costs of medical monitoring for potential cancer, and to be held responsible for consumers'…
A federal judge will hear arguments early next month on whether class action lawsuits calling for the makers of Zantac to pay for medical monitoring for consumers who may now…
A California state case may be the first Zantac cancer lawsuit to go before a jury in October 2022.
A federal judge has cleared the way for Zantac cancer lawsuits to proceed after rejecting an effort by defendants to have all the claims against them dismissed.
Two new FDA studies raise questions about previous claims Zantac converts into a cancer-causing chemical in the human body.
The first Zantac bellwether trial is expected to go before juries sometime in mid-2023, according to a schedule issued by the federal judge overseeing the consolidated litigation.
Attorneys have been appointed to leadership positions in Zantac lawsuits consolidated in California state court.
A federal judge is prepared to hear arguments over whether Zantac lawsuits filed over NDMA contamination and cancer claims can move forward on June 3 and 4.
Plaintiffs say Zantac manufacturers have destroyed evidence and intentionally delayed the discovery process for ongoing federal litigation in violation of court orders.
This week, Sanofi announced intentions to re-launch Zantac under the name Zantac 360, which will use the active ingredient from Pepcid instead of ranitidine, which has been linked to increased…